Loading stock data…
Loading stock data…
US$277.37
Get one email when NTRA crosses your level. Checked every 15 minutes during market hours.
▲ +4.71 (1.73%)up today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
65.8
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
14.57
Bearish momentumMACD below its signal line (15.58).
50-day average
229.81
Price aboveShort-term trend reference.
200-day average
214.77
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Diagnostics & Research
Natera Inc. is a diagnostics company specializing in advanced genetic testing services for patients, clinicians, and healthcare systems. The company focuses on analyzing cell-free DNA to support clinical decision-making across several key areas of medicine. Natera’s portfolio includes non-invasive prenatal tests that screen for chromosomal abnormalities, carrier screening tests for inherited genetic conditions, and products supporting in vitro fertilization through pre-implantation genetic testi…
www.natera.com12 strong buy · 14 buy · 4 hold · 0 sell · 0 strong sell (30 analysts, 2026-07-01)
11 strong buy · 13 buy · 3 hold · 0 sell · 0 strong sell (27 analysts, 2026-06-01)
11 strong buy · 14 buy · 3 hold · 0 sell · 0 strong sell (28 analysts, 2026-05-01)
10 strong buy · 15 buy · 3 hold · 0 sell · 0 strong sell (28 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-07 | -0.55 | -0.6 | ✗ Miss |
| 2026-02-26 | -0.53 | 0.36 | ✓ Beat |
| 2026-01-23 | 1.61 | 1.87 | ✓ Beat |
| 2025-11-06 | -0.35 | -0.64 | ✗ Miss |
| 2025-08-07 | -0.59 | -0.74 | ✗ Miss |
| 2025-05-08 | -0.66 | -0.5 | ✓ Beat |
| 2025-02-27 | -0.35 | -0.41 | ✗ Miss |
| 2024-11-12 | -0.59 | -0.26 | ✓ Beat |
Companies in the same industry, via Finnhub